Dr. Supriya Patel. Biosimilar insulins in diabetes management: A cost-effective shift in therapeutic options. Inn Phar Plan [Internet]. 2024 Apr. 1 [cited 2025 Sep. 19];12(1):16-9. Available from: https://www.innovationaljournals.com/index.php/ip/article/view/904